Tryp Therapeutics Inc. reported earnings results for the first quarter ended November 30, 2022. For the first quarter, the company reported net loss was CAD 1.63 million compared to CAD 3 million a year ago.
Tryp Therapeutics Inc. Canadian Securities Exchange
Equities
TRYP
CA89854F1062
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+34.27% | 51.07B | |
-8.03% | 38.78B | |
+35.88% | 38.61B | |
-10.62% | 27.32B | |
+12.10% | 26.35B | |
-18.91% | 19.46B | |
+41.34% | 13.58B | |
+29.49% | 12.46B | |
-4.06% | 11.75B |